BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32220323)

  • 1. Presymptomatic Increase of an Extracellular RNA in Blood Plasma Associates with the Development of Alzheimer's Disease.
    Yan Z; Zhou Z; Wu Q; Chen ZB; Koo EH; Zhong S
    Curr Biol; 2020 May; 30(10):1771-1782.e3. PubMed ID: 32220323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity and heterogeneity of extracellular RNA in human plasma.
    Galvanin A; Dostert G; Ayadi L; Marchand V; Velot É; Motorin Y
    Biochimie; 2019 Sep; 164():22-36. PubMed ID: 31108123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular RNA in a single droplet of human serum reflects physiologic and disease states.
    Zhou Z; Wu Q; Yan Z; Zheng H; Chen CJ; Liu Y; Qi Z; Calandrelli R; Chen Z; Chien S; Su HI; Zhong S
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19200-19208. PubMed ID: 31481608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHGDH expression increases with progression of Alzheimer's disease pathology and symptoms.
    Chen X; Calandrelli R; Girardini J; Yan Z; Tan Z; Xu X; Hiniker A; Zhong S
    Cell Metab; 2022 May; 34(5):651-653. PubMed ID: 35508105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma and serum extracellular small RNA reference profiles and their clinical utility.
    Max KEA; Bertram K; Akat KM; Bogardus KA; Li J; Morozov P; Ben-Dov IZ; Li X; Weiss ZR; Azizian A; Sopeyin A; Diacovo TG; Adamidi C; Williams Z; Tuschl T
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5334-E5343. PubMed ID: 29777089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
    Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum clusterin levels are not increased in presymptomatic Alzheimer's disease.
    IJsselstijn L; Dekker LJ; Koudstaal PJ; Hofman A; Sillevis Smitt PA; Breteler MM; Luider TM
    J Proteome Res; 2011 Apr; 10(4):2006-10. PubMed ID: 21280673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.
    Patra K; Soosaipillai A; Sando SB; Lauridsen C; Berge G; Møller I; Grøntvedt GR; Bråthen G; Begcevic I; Moussaud S; Minthon L; Hansson O; Diamandis EP; White LR; Nielsen HM
    Alzheimers Res Ther; 2018 Jan; 10(1):9. PubMed ID: 29378650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
    Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncharacterized RNAs in Plasma of Alzheimer's Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power.
    Barbagallo C; Di Martino MT; Grasso M; Salluzzo MG; Scionti F; Cosentino FII; Caruso G; Barbagallo D; Di Pietro C; Ferri R; Caraci F; Purrello M; Ragusa M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Throughput Sequencing of Extracellular RNA from Human Plasma.
    Danielson KM; Rubio R; Abderazzaq F; Das S; Wang YE
    PLoS One; 2017; 12(1):e0164644. PubMed ID: 28060806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    Williams SM; Schulz P; Rosenberry TL; Caselli RJ; Sierks MR
    J Alzheimers Dis; 2017; 58(1):23-35. PubMed ID: 28372328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-coding RNA BACE1-AS May Serve as an Alzheimer's Disease Blood-Based Biomarker.
    Fotuhi SN; Khalaj-Kondori M; Hoseinpour Feizi MA; Talebi M
    J Mol Neurosci; 2019 Nov; 69(3):351-359. PubMed ID: 31264051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospho-RNA-seq: a modified small RNA-seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma.
    Giraldez MD; Spengler RM; Etheridge A; Goicochea AJ; Tuck M; Choi SW; Galas DJ; Tewari M
    EMBO J; 2019 Jun; 38(11):. PubMed ID: 31053596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer's Disease before Symptom Onset.
    Palade J; Alsop E; Courtright-Lim A; Hsieh M; Whitsett TG; Galasko D; Van Keuren-Jensen K
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
    Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.